Giercksky+Nilssen AS
813 361 612 ↗Research and experimental development on natural sciences and engineeringAS · est 2014OsloParent · 1 subsidiary
Brreg · companies
headcount series appears after two register changes
Roles from Brreg, shown for business contact only. No birth date is shown or exported (purpose limitation, GDPR Art. 6(1)(f)).
Brreg · company_people
3 registered roles
| Daglig leder | Esben Are Nilssen Multiple boards Serial CEO | 2014-03-20 | |
| Styrets leder | Esben Are Nilssen Multiple boards Serial CEO | 2014-03-20 | |
| Styremedlem | Tone Cathrine Giercksky Multiple boards | 2014-03-20 |
NOK, amounts in thousands
| 2024 | 2025 | ||
|---|---|---|---|
| Revenue | 323 | ||
| Operating result | 181 | ||
| Result before tax | 510 | ||
| Net result | 461 | ||
| Total assets | 1 430 | ||
| Equity | 1 330 |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue | 323 | ||||||
| Operating result | 181 | ||||||
| Result before tax | 510 | ||||||
| Net result | 461 | ||||||
| Total assets | 1 430 | ||||||
| Equity | 1 330 |
Regnskapsregisteret · company_revenue · FY2025 (company)
register ledger · money
| 2026-05-09 | reg | accounts_filed: sisteInnsendteAarsregnskap | 2024 -> 2025 |
No corporate shareholders recorded.
Aksjonærregisteret · company_ownership · both directions
| 2024 | 2025 | 2026 | |
|---|---|---|---|
| auditor — | |||
| accountant — |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|
| auditor — | |||||||
| accountant — |
Brreg · company_org_roles
No recorded tender wins.
Relevant open tenders — matched · NACE 72.100 ↔ CPVsubscribers sharpen matches with per-company keywords
open-tender matching (NACE ↔ CPV) awaits Intelligo's open-tenders view
Doffin/TED · company_tender_wins · 2026-08-17
No job ads on record in the last 12 months.
NAV Arbeidsplassen · company_job_ad_months
Web · company_sites
Group revenue kr 323kGroup net kr 455kTenders won 0Rolled up across the parent + 1 subsidiary — Alarmin Therapeutics AS alone is kr 0.
rollup estimate · filed konsernregnskap not yet in Intelligo
| Alarmin Therapeutics AS | 50% | Research and experimental development on natural sciences and engineering | kr 0 |
| Lilleborg Legekontor AS | 25% | ||
| 1.6% | |||
| Pre Diagnostics AS | 1.1% | ||
| Sparebank 1 Nord-Norge | 0.0% | ||
| Sparebank 1 SMN | 0.0% | ||
| Sparebanken Norge | 0.0% | ||
| Aker BP ASA | 0% | ||
| Wallenius Wilhelmsen ASA | 0% | ||
| Gjensidige Forsikring ASA | 0% | ||
| Orkla ASA | 0% | ||
| Storebrand ASA | 0% | ||
| Equinor ASA | 0% |
+3 more holdings
Aksjonærregisteret · company_ownership · both directions
This company's annual report has not been read yet. The filed figures above come from the accounts form; everything the board wrote around them is in the PDF, which is read on request.
Regnskapsregisteret (årsberetning) · company_annual_reports
registered 2014-03-20audit opt-out 2014-03-20
Brreg · companies
register ledger · 1 event
| 2026-05-09 | reg | accounts_filed: sisteInnsendteAarsregnskap | 2024 -> 2025 |
Skiwo · company_events